J Cell Biol 4 — EMBO J 30 23 — Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators. J Innate Immun 5 5 —9. Brough D, Rothwell NJ. Caspasedependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci Pt 5 — Glia 49 4 —9. J Immunol 3 — Nishimoto N, Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 4 4 — Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model.
Crit Care Med 39 6 — IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14 6 — The pro- and anti-inflammatory properties of the cytokine interleukin Biochim Biophys Acta 5 — Interleukindeficient mice develop hepatic inflammation and systemic insulin resistance.
Diabetologia 53 11 — Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha.
J Cell Biol 1 — Cytokine Growth Factor Rev 11 4 — ILand IL in health and disease. Cytokine Growth Factor Rev 25 4 — Interleukin-2 enhances the response of natural killer cells to interleukin through up-regulation of the interleukin receptor and STAT4.
Blood 95 10 — Mechanisms of cytokine secretion: a portfolio of distinct pathways allows flexibility in cytokine activity. Eur J Cell Biol 90 6—7 — A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils.
Allergy 61 6 — Cdcmediated MTOC polarization in dendritic cells controls targeted delivery of cytokines at the immune synapse. J Exp Med 12 — Effect of interleukin on mouse core body temperature.
Eur J Immunol 35 2 — WSX-1 is required for the initiation of Th1 responses and resistance to L. Immunity 15 4 — Interleukin 27 negatively regulates the development of interleukin producing T helper cells during chronic inflammation of the central nervous system.
Nat Immunol 7 9 — Mosser DM, Zhang X. Interleukin new perspectives on an old cytokine. Immunol Rev 1 — IL inhibits cytokine production by activated macrophages. J Immunol 11 — Interleukin differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo.
Immunology 94 1 —8. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CDactivated naive human B cells to secrete immunoglobulin A.
J Exp Med 3 — Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Interleukin IL inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages.
Biochem Biophys Res Commun 3 —9. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets — a review of the current knowledge. J Clin Immunol 34 5 — Recycling endosome-dependent and -independent mechanisms for IL secretion in LPS-activated macrophages.
J Leukoc Biol 92 6 — Travis MA, Sheppard D. Annu Rev Immunol 32 — Immunity 21 4 — Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30 — Stem Cells 15 3 —7. Mini-review series: focus on chemokines. Immunol Cell Biol 89 2 —4. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 5 — Pelus LM, Fukuda S. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
Exp Hematol 34 8 — The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum Gene Ther 11 2 — Genomics 6 3 — Eur J Immunol 26 2 —9. Human SCAMP5, a novel secretory carrier membrane protein, facilitates calcium-triggered cytokine secretion by interaction with snare machinery. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J Leukoc Biol 76 1 — Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization.
Leuk Lymphoma 43 2 — Chemokine-protease interactions in cancer. Semin Cancer Biol 14 3 —8. Eur J Immunol 34 7 — Chemokines as mediators of neovascularization.
Arterioscler Thromb Vasc Biol 28 11 — Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood :e— Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.
Kidney Int 84 4 — Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol 42 1 — Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
Am J Pathol 3 — Sibley LD. Invasion and intracellular survival by protozoan parasites. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 7 5 — Buruli ulcer: advances in understanding Mycobacterium ulcerans infection.
Dermatol Clin 29 1 :1—8. Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 68 2 — Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
Science —7. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 7 1 — Hall B, Simmonds R. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
Biochem Soc Trans 42 1 — Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
Infect Immun 75 8 — The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER. PLoS Pathog 10 4 :e Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7 5 :e Kedzierski L.
Leishmaniasis vaccine: where are we today? J Glob Infect Dis 2 2 — Moradin N, Descoteaux A. Leishmania promastigotes: building a safe niche within macrophages. Front Cell Infect Microbiol 2 Lodge R, Descoteaux A. Leishmania invasion and phagosome biogenesis. Subcell Biochem 47 — Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions.
Cell Microbiol 16 10 — Yao C. Major surface protease of trypanosomatids: one size fits all? Infect Immun 78 1 — Targeted gene deletion in Leishmania major identifies leishmanolysin GP63 as a virulence factor. Mol Biochem Parasitol 1 — Cell Host Microbe 14 1 — Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases.
Sci Signal 2 90 :ra Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 9 4 — The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation.
Leishmania -induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP PLoS Pathog 6 10 :e Leishmania donovani targets Dicer1 to downregulate miR, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 13 3 — Leishmania dices away cholesterol for survival. Cell Host Microbe 13 3 —7. New Microbiol 20 3 — Matte C, Olivier M.
Leishmania -induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis 5 — Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania. J Inflamm Lond 7 1 Leishmania major parasite stage-dependent host cell invasion and immune evasion.
Leishmania major : low infection dose causes short-lived hyperalgesia and cytokines upregulation in mice. Exp Parasitol 3 — Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli Pneumonia. J Infect Dis 3 —9. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U cell line. Blood 91 1 — The role of interleukin IL in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti—IL receptor antibody for sterile cure.
Certain chemokines promote angiogenesis. Chemokines also regulate the movement of B-lymphocytes, T-lymphocytes, and dendritic cells through the lymph nodes and the spleen. When produced in excess amounts, chemokines can lead to damage of healthy tissue as seen in such disorders as rheumatoid arthritis, pneumonia, asthma, adult respiratory distress syndrome ARDS , and septic shock.
Chemokines are produced by many cells including leukocytes, endothelial cells, epithelial cells, and fibroblasts. IL is a primary mediator of early innate immune responses to intracellular microbes.
It is also an inducer of cell-mediated immunity. It functions to stimulate the synthesis of interferon-gamma by T-lymphocytes and NK cells ; increases the killing activity of cytotoxic T-lymphocytes and NK cells; and stimulates the differentiation of naive T4-lymphocytes into interferon-gamma producing T H 1 cells. It is produced mainly by macrophages and dendritic cells. Interferons modulate the activity of virtually every component of the immune system.
Type I interferons include 13 subtypes of interferon-alpha, interferon-beta, interferon omega, interferon-kappa, and interferon tau. There is only one type II interferon, interferon-gamma, which is involved in the inflammatory response. Signaling pattern recognition receptors located in the cytoplasm of cells such as RIG-1 and MDA-5 also signal synthesis and secretion of type-I interferons.
Type I interferons, produced abundantly by plasmacytoid dendritic cells, by virtually any virus-infected cell, and by other defense cells provide an early innate immune response against viruses. Interferons induce uninfected cells to produce an enzyme capable of degrading viral mRNA, as well as one that blocks translation in eukaryotic cells.
These enzymes remain inactive until the uninfected cell becomes infected with a virus. At this point, the enzymes are activated and begin to degrade viral mRNA and block translation in the host cell. They also promote body defenses by enhancing the activities of CTLs, macrophages, dendritic cells, NK cells, and antibody-producing cells, as well as induce chemokine production to attract leukocytes to the area.
Type I interferons also induce MHC-I antigen expression needed for recognition of antigens by cytotoxic T-lymphocytes ; augment macrophages, NK cells, cytotoxic T-lymphocytes, and B-lymphocytes activity; and induce fever.
IL-6 functions to stimulate the liver to produce acute phase proteins ; stimulates the proliferation of B-lymphocytes ; and increases neutrophil production. IL-6 is produced by many cells including T-lymphocytes, macrophages, monocytes, endothelial cells, and fibroblasts. IL is an inhibitor of activated macrophages and dendritic cells and as such, regulates innate immunity and cell-mediated immunity. IL is produced mainly by macrophages, and T H 2 cells. IL stimulates NK cell proliferation and proliferation of memory T8-lymphocytes.
These molecules orchestrate a variety of processes ranging from the regulation of local and systemic inflammation to cellular proliferation, metabolism, chemotaxis, and tissue repair. In other organisms, such as fruit flies and lizards 6 , cytokine-like molecules are known to regulate host defense and temperature homeostasis.
The primary function of cytokines is to regulate inflammation, and as such, play a vital role in regulating the immune response in health and disease. There are proinflammatory and anti-inflammatory cytokines. Each cytokine binds to a specific cell surface receptor to generate a cell signaling cascade that affects cell function. This includes the positive or negative regulation of several genes and their transcription factors.
Each cytokine is produced by a cell population in response to different stimuli; they induce an array of agonist, synergistic, or antagonistic effects that functionally alter target cells. A primary feature of cytokine biology is that of functional redundancy: different cytokines share similar functions. Furthermore, cytokines are pleiotropic since they act on many different cell types, and cells may express more than one receptor for a given cytokine.
To generalize the effect of a particular cytokine is virtually impossible. Cytokines are classified as paracrine if the action in the vicinity of the place of release is restricted, autocrine if the cytokine acts on the cell that secretes it, and endocrine if the cytokine reaches remote regions of the body.
Most cytokines are short-lived and act locally in an autocrine and paracrine fashion. Cytokines are mainly produced by macrophages and lymphocytes, although they can also be produced by polymorphonuclear leukocytes PMN , endothelial and epithelial cells, adipocytes, and connective tissue. Cytokines are essential to the functions of macrophages.
Multiple subsets of macrophages have been characterized depending on the origin and microenvironment in which the macrophage is found. Contingent on activation status, macrophages have been classified as classically and alternatively activated. In turn, these different macrophage types drastically differ in the cytokines that they secrete, and consequently, their functions 8.
The process of cytokine secretion is masterfully regulated by a series of interorganellar exchanges that rely on vesicular trafficking and cytoskeletal remodeling 9. Proteins regulating neurotransmitter release, notably members of the soluble N -ethylmaleimide-sensitive factor attachment protein receptor SNARE family 9 , 10 , and more recently synaptotagmins Syt 11 , are pivotal for the spatiotemporal regulation of cytokine secretion.
In immune cells, SNAREs and Syts have been found to regulate processes ranging from cytokine trafficking to cell migration and phagocytosis. This review will present the functions of macrophage cytokines and, where known, summarize findings on how these cytokines are released. The types of macrophages that secrete these cytokines will also be depicted. To illustrate the importance of macrophage cytokines in health and disease, we will describe selected examples of how pathogens use cytokines to their advantage.
Although monocytes and macrophages are the main sources of these cytokines, they are also produced by activated lymphocytes, endothelial cells, and fibroblasts. Additionally, macrophages release chemokines, leukotrienes, prostaglandins, and complement. All of these molecules, in concert, may induce increased vascular permeability and recruitment of inflammatory cells. Aside from local effects, these mediators also produce systemic effects such as fever and the production of acute inflammatory response proteins.
The inflammatory response is beneficial for the host when the aforementioned cytokines are produced in appropriate amounts, but toxic when produced in a deregulated fashion. It stimulates the acute phase of the immune response.
This potent pyrogenic cytokine is one of the first to be released in response to a pathogen, and is able to exert its effects in many organs As such, TNF is one of the main cytokines responsible for septic shock. In the hypothalamus, TNF stimulates the release of corticotropic releasing hormone, suppresses appetite, and induces fever.
In liver, it stimulates the acute inflammatory response by elevating the synthesis of C-reactive protein and other mediators.
TNF induces vasodilation and loss of vascular permeability, which is propitious for lymphocyte, neutrophil, and monocyte infiltration. It helps recruit these cells to the inflammation site by regulating chemokine release.
This in turn increases CXCR2-dependent neutrophil migration to the inflammation site. Being an inducer of the inflammatory response, excess amounts of TNF have been found to play pathological roles in ailments such as inflammatory bowel disease, psoriasis, rheumatoid arthritis, asthma, cancer, infectious diseases, and other auto-immune pathologies.
Some of these conditions are currently co-treated with monoclonal antibodies that neutralize this cytokine In macrophages, TNF is released to the extracellular milieu via the constitutive secretion pathway, and its trafficking is the best understood of all cytokines 9 , 17 , Details on TNF trafficking will be discussed in another article of this issue. Rho1 and Cdc42, two proteins that govern cell shape via actin remodeling, also regulate the post-recycling endosome trafficking of TNF to the plasmalemma Moreover, LPS was found to increase the expression of vesicle trafficking proteins that regulate TNF trafficking 17 , The process of phagocytosis requires extensive membrane exocytosis from several organelles that also partake in TNF secretion 7.
Interestingly, it was found that TNF is not only secreted to the extracellular milieu at the plasma membrane, but also in a polarized manner at the phagocytic cup This highlights an efficient and elegant strategy where macrophages can promptly release cytokines at the same time that they phagocytose microbial invaders. The importance of regulating TNF secretion implies that there exist negative regulators for its secretion. One such regulator is the recently characterized protein Syt XI, which associates to recycling endosomes and lysosomes in macrophages 11 , Syts constitute a group of membrane proteins that regulate vesicle docking and fusion in processes such as exocytosis 11 , 23 and phagocytosis 11 , 24 , However, Syt XI cannot bind calcium and inhibits vesicle fusion The inverse is true when Syt XI is overexpressed It is also a chemoattractant for granulocytes, enhances the expansion and differentiation of CD4 T cells 29 , and increases the expression of cell adhesion molecules on leukocytes and endothelial cells.
IL-1Ra is secreted via the classical secretory, though the exact mechanism is not well known. It can also exert its effects in an intracrine fashion and act as a transcription factor 29 , After activation, autophagy plays a major role in the release of this cytokine. Autophagy is a highly conserved process in eukaryotes in which the cytoplasm, aberrant, or damaged organelles are sequestered in double-membrane vesicles and released into the lysosome for breakdown and eventual recycling of resulting macromolecules This process plays a crucial role in adaptation to changing environmental conditions, starvation, cellular remodeling during development, and senescence.
Autophagy is characterized by the formation of double-membrane vesicles, called autophagosomes, which capture and transport cytoplasmic material to acidic compartments where material is degraded by hydrolytic enzymes Additionally, exocytosis of P2X7R-positive multivesicular bodies containing exosomes has also been reported to play an important role in the release of this cytokine The various modes of IL-1 secretion highlight the exquisite machinery that macrophages have evolved as a means for rapidly responding to inflammatory stimuli.
IL-6 is a pleiotropic cytokine that has both proinflammatory and anti-inflammatory functions that affect processes ranging from immunity to tissue repair and metabolism. It promotes differentiation of B cells into plasma cells, activates cytotoxic T cells, and regulates bone homeostasis. Proinflammatory properties are elicited when IL-6 signals in trans via soluble IL-6 receptors binding to gp, which is ubiquitous in all cells.
Inhibition of trans signaling via gp blockade in murine sepsis models rescues mice from widespread inflammation and death IL-6 trans signaling also leads to recruitment of monocytes to the inflammation site 42 , promotes the maintenance of Th17 cells, and inhibits T cell apoptosis and development of Tregs In contrast, anti-inflammatory properties are elicited when IL-6 signals through the classical pathway, which occurs via the IL-6 receptor that only few cells express.
IL-6 classic signaling also mediates apoptosis inhibition and the regeneration of intestinal epithelial cells IL-6 is a soluble cytokine that is synthesized in the ER and, unlike TNF, is not processed as a membrane-bound precursor.
Golgi-derived vesicles then fuse with VAMP3-positive recycling endosomes. Three-dimensional reconstruction of fluorescence images showed that recycling endosomes can harbor both TNF and IL-6, albeit both occupy different subcompartments IL is produced primarily by monocytes, macrophages, and other antigen-presenting cells; it is essential for fighting infectious diseases and cancer.
IL is a heterodimeric cytokine comprised of the p35 and p40 subunits, which come together after their synthesis. Deletions within the p40 gene have been observed in patients suffering from concurrent multiple bacterial infections 46 , IL promotes cell-mediated immunity via stimulation of Th1 cells. The involvement of this cytokine in these processes has made it a target in both auto-immune pathologies and cancer 46 , After protein synthesis, both p40 and p35 subunits associate at the ER, where they undergo subsequent glycosylation steps prior to being released at the cell membrane Although the precise post-Golgi trafficking mechanisms in macrophages are not known, the release route is likely to resemble that of TNF and IL-6 9.
Furthermore, IL is secreted in a polarized manner from lymphocytes; this process is dependent on Cdc42 52 , which also regulates release of TNF to the plasma membrane. This raises the interesting prospect that IL may be released in a polarized fashion, along with TNF 17 , at nascent macrophage phagosomes.
It is similar to IL in that both induce inflammation. IL is a member of the IL family, and is composed of subunits p28 and Epstein—Barr virus-induced gene 3. IL also has anti-inflammatory properties, which are exemplified by the fact that IL receptor-deficient mice are more susceptible to auto-immune encephalomyelitis, which correlates with increased levels of Th17 cells The fact that this cytokine has selective inflammatory and anti-inflammatory properties supports the concept that the inflammatory response is prompt, but also carefully calibrated to avoid damage to the host.
Inflammation is tightly regulated by multiple inhibitors and antagonists. IL is a 35 kD cytokine identified in , and is produced by activated macrophages, B cells, and T cells IL suppresses MHC-II expression in activated macrophages and is thus a potent inhibitor of antigen presentation Experiments in murine models have shown that blocking or neutralizing IL leads to increased levels of TNF and IL-6; on the contrary, exogenous IL improves survival and reduces the levels of inflammatory cytokines It has been observed that reduced levels of IL favor the development of gastrointestinal pathologies such as inflammatory bowel disease Recombinant IL has indeed been effective in the treatment of some of these diseases.
Independent of recycling endosomes, IL was also observed to exit directly from the Golgi to the cell surface in apoE-labeled vesicles Transforming growth factor beta is synthesized as a precursor and is directed to the ER by virtue of its signal peptide. Cleavage by the endoprotease furin, which can happen at the ER or in the extracellular environment, is required for activation of this cytokine Although the secretory mechanism of this cytokine has not been explored, it is possible that it follows a post-Golgi pathway similar to that of TNF, IL-6, or IL Chemokines are a special family of heparin-binding cytokines that are able to guide cellular migration in a process known as chemotaxis.
Cells that are attracted by chemokines migrate toward the source of that chemokine. During immune surveillance, chemokines play a crucial role in guiding cells of the immune system to where they are needed In the inflammatory response, chemokines are released by a wide variety of cells involved in both innate and adaptive immunity Below is a description of the main chemokines released by macrophages.
Both chemokines are angiogenic and may promote the development of tumors such as melanomas CCL5, or the regulated upon activation normal T cell expressed and secreted RANTES , is an inflammatory chemoattractant for T cells, basophils, eosinophils, and dendritic cells to the site of inflammation Similar to CXCL1 and 2, it promotes tumorigenesis and metastasis CCL5 is synthesized in the ER and traffics to the Golgi complex before being exported outside of the cell.
CXCL8 is a potent chemoattractant for neutrophils, in which it also induces degranulation and morphological changes 78 , Since macrophages are some of the first cells to respond to an antigen, they are likely the first cells to release CXCL8. Other cells such as keratinocytes, endothelial cells, eosinophils, and basophils also respond to this chemokine. CXCL9, also known as monokine induced by gamma interferon MIG , is a strong T cell chemoattractant to the site of inflammation 71 , It mediates cell recruitment necessary for inflammation and repair of tissue damage.
CXCL9 also inhibits neovascularization 83 and has anti-tumor and anti-metastatic effects CXCL10, or interferon gamma-induced protein 10, is secreted not only by monocytes and macrophages, but also by fibroblasts and endothelial cells It serves to attract T cells, NK cells, dendritic cells 84 , and also has potent anti-cancer activity. It also inhibits angiogenesis and tumor formation Polarization signals may be apoptotic cells, hormones, immune complexes, or cytokines provided by lymphocytes or other cells.
In addition, M1 macrophages secrete high levels of reactive oxygen species ROS and reactive nitrogen species RNS , produce and secrete iNOS, and promote the metabolism of arginine into nitric oxide and citrulline. As a result, M1 macrophages foster a highly microbicidal environment, and have a role in mediating the destruction of pathogens and tumor cells.
M1-derived chemokines help recruit NK and Th1 cells. In stark contrast, exposure or treatment of monocytes with IL-4 and IL polarizes these cells toward an M2a phenotype 8 , Those macrophages express a series of chemokines that promote the accrual of Th2 cells, eosinophils, and basophils. Through chemokine production, M2b macrophages also promote recruitment of eosinophils and Tregs that foster a Th2 response. They also express high levels of arginase and promote tissue regeneration and angiogenesis 8 , The capacity of M2c macrophages to induce Tregs makes them more effective than M2a macrophages at protecting organs from injury caused by inflammatory infiltrates Macrophage bias is reversible.
For example, if an M1 macrophage is given apoptotic cells, it may transform into an M2 macrophage. Monocytes can become phenotypically distinct macrophages.
Upon encountering different stimuli, monocytes turn into highly microbicidal M1 , or into immunosuppressive macrophages M2. Stimuli can range from microbial substances to biochemical signals provided by the microenvironment of a given tissue.
Many of the cytokines that bias macrophage phenotype are provided by surrounding lymphocytes or other non-immune cells. Macrophage subtypes release a vastly different array of cytokines and chemokines that can either promote inflammation and sometimes tissue destruction, or wound healing and tissue repair. M1 macrophages are known to be tumor suppressive whereas M2 macrophages generally promote tumorigenesis. It is important to note that macrophage bias is a spectrum and is reversible. IC, immune complexes; ApC, apoptotic cells; Gluc, glucocorticoids.
The characteristics of M1 and M2 macrophages have implicated them in the development of infectious disease and cancer. For example, helminth-derived molecules can strongly bias macrophages toward an M2 phenotype. The cytokines and associated Th2 response that ensues promote immunosuppression and parasite survival In cancer, tumor-associated macrophages TAMs have been known to either promote or hinder neoplasia 8 , In colorectal cancer, TAMs are inflammatory and promote the development of a Th1 response In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis 8 , The contribution of alternatively activated macrophages and their cytokines to disease has made them a target for immunotherapies that seek to alter the phenotypic bias of macrophage populations.
For instance, helminth-derived molecules could be used to alter the proinflammatory cytokine profile of colitis-associated macrophages The evolutionary race that has taken place over millions of years among pathogens and their hosts has given rise to a multitude of adaptations that have allowed these pathogens to resist the defenses mounted by their hosts. Several of these adaptations endow pathogens to evade the immune system in order to survive destruction and thrive.
Both intracellular and extracellular parasites have evolved mechanisms to not only avoid or survive the immune response, but also to use it for their own benefit 93 , Upregulating or downregulating the production and release of macrophage cytokines can have profound effects on the immune response. A variety of pathogenicity factors target these important molecules of the immune system. The following examples describe how certain pathogens, depending on their needs, deregulate cytokine secretion to aid in their survival and dissemination.
Mycobacteria are intracellular pathogens that cause a variety of human diseases that are difficult to treat. Due to their particular cell wall, these bacteria are very resistant to antibiotics and innate host defenses. Lesions can cause incapacitation, disfigurement, and severe deformities The disease is the third-most common mycobacterial infection and affects areas of the world with hot and humid climates.
It causes broad tissue damage in the absence of an acute inflammatory response. Injection of mycolactone alone can induce lesions similar to those caused by infection In contrast to other mycobacterial infections, M. This may be explained by the fact that mycolactone inhibits phagocytosis and hampers phagolysosomal maturation in macrophages 98 , Although the mechanism for these findings was unknown, data from multiple studies suggested that inhibition was at the post-transcriptional level.
Indeed, Hall et al. That finding prompted the investigators to check whether TNF was being translocated to the ER for processing. Interestingly, inhibiting the 29S proteasome showed that non-glycosylated TNF accumulates in the cytoplasm of mycolactone-treated macrophages, indicating that this causes the failure in TNF secretion. In the presence of mycolactone, TNF is not protected from proteinase K digestion, indicating that this cytokine does not translocate into the ER under these conditions.
These effects were found not to be due to mycolactone disrupting ER membrane integrity or due to induction of ER-associated degradation pathways. It would be interesting to investigate whether mycolactone can physically block the channel activity of the Sec61, or that of other ER translocons. These findings were made more general by showing that — in many cell types — mycolactone was inhibiting the translocation of several secreted and membrane proteins into the ER.
Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages Quenching cytokine production in this way can thus severely obstruct the development of the immune response and promote the survival of M.
0コメント